ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Improving High-Temperature Operational Stability of Inverted Perovskite Solar Cells Through MXene Heat-Dissipating Layers.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Despite inverted perovskite solar cells (iPSCs) having reached power conversion efficiencies (PCEs) of about 27% with long-term stability at room temperature, their commercial devices must prevent heat-induced performance degradation. In PSCs, 2D MXenes have been employed to enhance their long-term stability at high temperatures; however, a deep understanding of the heat management mechanism of applying MXenes at interfaces is still lacking. Herein, we investigate the application of MeO-2PACz-functionalized MXenes at the hole transport layer (HTL) interface in iPSCs using MeO-2PACz as the HTL. PSCs reached PCEs of 23.02 ± 1.14%, observing a 400% enhancement in their operational stability, spanning the T
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.